Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.
Steven E. Schutzer(Rutgers, The State University of New Jersey), Benjamin J. Luft(Stony Brook School), Lauren Krupp(New York University), Raymond J. Dattwyler(New York Medical College), Patricia K. Coyle(St. Michael's Hospital), Anita Belman(Rutgers, The State University of New Jersey), Z. Deng(Rutgers, The State University of New Jersey)
Cited by 47
Related Papers
Randomized, comparative study of interferon β-1a treatment regimens in MS
|Neurology|2002|633
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
|The Lancet Neurology|2008|484
Treatment of Neuromyelitis Optica With Rituximab
|Archives of Neurology|2008|460
Recommendations for cognitive screening and management in multiple sclerosis care
|Multiple Sclerosis Journal|2018|404
Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis
|Annals of Neurology|2010|332